Exoskeleton walking with spinal stimulation for bone and muscle health
Tests exoskeleton walking with spinal stimulation in adults with spinal cord injury.
Key facts
- Who runs it
- Bronx VA Medical Center
- Where
- West Orange, United StatesSee the site
- Trial code
- Registry title
- The Effect of Exoskeletal-assisted Walking Combined With Transcutaneous Spinal Cord Stimulation on Bone Strength.
- Status
- Not yet recruiting
- People taking part
- 24 people, planned
- Started
- 1 Jul 2026
- Expected to end
- 1 Jun 2033
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Exoskeleton-Assisted Walking (EAW) + active Transcutaneous Spinal Cord Stimulation (tSCS)
- Exoskeleton-assisted walking (EAW) + sham Transcutaneous Spinal Cord Stimulation (tSCS)
- Record updated
- 8 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 21-60 with a long-standing spinal cord injury who use a wheelchair all the time and can still move their legs somewhat. It tests walking with an exoskeleton plus spinal stimulation on muscle and bone health.
- Age
- 21 to 60 years
- Sex
- All sexes can join.
- Disease stage
- Spinal cord injury more than 3 years ago, grade C or D on the ISNCSCI exam, with a leg motor score of 16 or more. Injury level between C5 and T10. Wheelchair use 100% of the time.
- Earlier treatment
- People currently in a gym or rehabilitation program with walking training such as exoskeleton-assisted walking cannot join. People taking medicines that affect muscle or bone cannot join.
- Biomarker or test result
- A bone density scan (DXA) must not be below the cutoffs: hip T-score under -3.5, or knee bone density under 0.60 g/cm2.
Main reasons for not taking part
- History of fragility or traumatic fractures, unhealed fractures, or swelling, bruising or discoloration of the legs
- Current bone disease such as osteomyelitis or hyperparathyroidism
- Positive pregnancy test, or planning to become pregnant during the study
- Baclofen pump, metal in the body, pacemaker or other implanted electrical device
- Claustrophobia or not medically safe for an MRI scan
The registry criteria, word for word
Show all 7 criteriaShow less
Who cannot take part
- Body metal, including any of the following:; metal fragments or pieces in eyes or any other part of body; pacemakers or other implanted electrical devices; aneurysm clips (metal clips on wall of a large artery); metallic prostheses (metal pins and heart valves); internal hearing aids (cochlear implants); permanent eyeliner; shrapnel fragments; piercing that cannot be removed
- Medically unsafe to receive an MRI scan
- Claustrophobia
- Baclofen pump
Other criteria
- Participant Screening:; International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) neurological assessment examination to determine the level and completeness of SCI when participants screen for entry into the study. The ISNCSCI exam will be performed by the study physician using a tool that assesses sensory function (light touch and pinprick) in each dermatome (A dermatome is an area of skin that sends touch, pain, temperature, and other sensory signals back to the brain) and motor function (motor function is a general term to describe the way muscles create movement) in ten key muscles. This test will determine the level of SCI, defined as the lowest spinal level with normal function, and assigns a classification of severity according to the ISNCSCI scale. In this study, both ISNCSCI grade C and grade D would make a participant eligible for this study; DXA study to assess bone mineral density (BMD) at the total hip (TH), distal femur (DF), and proximal tibia (PT) that will be compared to the cutoff values described in the exclusion criteria section; Medical history and exam to ensure medical health, anthropometric compatibility for EAW, and to identify fragility or traumatic fractures, unhealed fractures, and signs of swelling, bruising, and discoloration of the legs
- Inclusion Criteria:; Between the ages of 21-60 years old; Non-walkers with an SCI greater than 3 years post injury; As measured by a member of the study staff, participants who have a lower extremity motor score greater or equal to 16 on the INSCSCI exam with an impairment grade of C or D; Neurologic level of injury as determined by study staff between C5-T10 (completed at participant's screening); Capable of gripping Lofstrand crutches and/or a walker without assistance; Wheelchair reliant 100% of the time; Height is between 62 inches and 74 inches; Weight less than 220lbs; Anthropometric compatibility with the EAW device:; Thigh length between 14 and 19 in (36 and 48 cm); Shank length between 17 and 22 in (43 and 55 cm)
- Exclusion Criteria:; As determined by the study physician from the screening health exam, a history of fragility or traumatic fractures, unhealed fractures, and signs of swelling, bruising, and discoloration of the legs; Current bone disease diagnosis (e.g., osteomyelitis, hyperparathyroidism); As determined by the study physician from the screening DXA study, a T-score at the total hip < -3.5 or aBMD of the knee (proximal tibia and/or distal femur) < 0.60 g/cm2 from the DXA screen; Positive pregnancy test at any of the study intervention or assessment visits, or if female participants plan to become pregnant over the course of the study, they will be excluded or withdrawn (if already enrolled) from participation; Currently in a gym/rehabilitation program performing ambulatory interventions such as EAW, as determined by the study staff; Currently prescribed any medications that can affect muscle and/or bone metabolism, as determined by the study staff
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 21 and 60 years old?
Where in United States
- Kessler FoundationWest Orange, United StatesNot yet recruiting
About the trial
What the trial wants to find out
Immobilization following spinal cord injury (SCI) results in muscle and bone loss below the level of injury, which ultimately predisposes to fracture at several sites throughout the legs and can lead to several medical complications that can devastate quality of life. There is a scarcity of research that has successfully implemented rehabilitation and/or exercise training interventions to preserve the musculoskeletal system during the acute phase SCI, or possibly reverse the muscle and bone loss that has already occurred in chronic SCI. This study will compare the effect of exoskeleton-assisted walking (EAW) training combined with transcutaneous spinal cord stimulation (tSCS) (EAW + active tSCS), to that of EAW + sham tSCS, on measures of muscle and bone health in a cohort of chronically injured motor incomplete SCI. A successful outcome would expand treatment options to improve musculoskeletal health over the lifetime.
The 2 groups in the trial
- Exoskeleton-Assisted Walking (EAW) + active Transcutaneous Spinal Cord Stimulation (tSCS)Treatment being tested
The EAW + active tSCS group will receive simultaneous lumbosacral tSCS while simultaneously performing EAW.
- Exoskeleton-assisted walking (EAW) + sham Transcutaneous Spinal Cord Stimulation (tSCS)Sham treatment, for comparison
The EAW + sham tSCS group will receive simultaneous lumbosacral sham tSCS while simultaneously performing EAW. Participants in both groups will receive 60 minutes of EAW + sham tSCS overground training per session for a total of 108 sessions (3 X week for 36 weeks).
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Exoskeletal-assisted Walking Combined With Transcutaneous Spinal Cord Stimulation: Effect on Imaging and Serum Biomarkers of Skeletal Muscle Mass and Bone Strength.
- Plain-language title
- Exoskeleton walking with spinal stimulation for bone and muscle healthGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Fit questions
- Built from NCT07325149, who can take part
- Record updated
- 8 January 2026